Lemke CD - Search Results

1

Biodegradable microparticles loaded with doxorubicin and CpG ODN for in situ immunization against cancer.

Makkouk A, Joshi VB, Wongrakpanich A, Lemke CD, Gross BP, Salem AK, Weiner GJ. Makkouk A, et al. Among authors: lemke cd. AAPS J. 2015 Jan;17(1):184-93. doi: 10.1208/s12248-014-9676-6. Epub 2014 Oct 18. AAPS J. 2015. PMID: 25331103 Free PMC article.

2

Three steps to breaking immune tolerance to lymphoma: a microparticle approach.

Makkouk A, Joshi VB, Lemke CD, Wongrakpanich A, Olivier AK, Blackwell SE, Salem AK, Weiner GJ. Makkouk A, et al. Among authors: lemke cd. Cancer Immunol Res. 2015 Apr;3(4):389-98. doi: 10.1158/2326-6066.CIR-14-0173. Epub 2015 Jan 27. Cancer Immunol Res. 2015. PMID: 25627654 Free PMC article.

3

Tumor immunotherapy using adenovirus vaccines in combination with intratumoral doses of CpG ODN.

Geary SM, Lemke CD, Lubaroff DM, Salem AK. Geary SM, et al. Among authors: lemke cd. Cancer Immunol Immunother. 2011 Sep;60(9):1309-17. doi: 10.1007/s00262-011-1038-y. Epub 2011 May 28. Cancer Immunol Immunother. 2011. PMID: 21626029 Free PMC article.

4

Nanoparticle delivery systems in cancer vaccines.

Krishnamachari Y, Geary SM, Lemke CD, Salem AK. Krishnamachari Y, et al. Among authors: lemke cd. Pharm Res. 2011 Feb;28(2):215-36. doi: 10.1007/s11095-010-0241-4. Epub 2010 Aug 19. Pharm Res. 2011. PMID: 20721603 Free PMC article. Review.

5

Antigen-coated poly α-hydroxy acid based microparticles for heterologous prime-boost adenovirus based vaccinations.

Lemke CD, Geary SM, Joshi VB, Salem AK. Lemke CD, et al. Biomaterials. 2013 Mar;34(10):2524-9. doi: 10.1016/j.biomaterials.2012.12.030. Epub 2013 Jan 11. Biomaterials. 2013. PMID: 23312902 Free PMC article.

6

The combination of a low-dose chemotherapeutic agent, 5-fluorouracil, and an adenoviral tumor vaccine has a synergistic benefit on survival in a tumor model system.

Geary SM, Lemke CD, Lubaroff DM, Salem AK. Geary SM, et al. Among authors: lemke cd. PLoS One. 2013 Jun 28;8(6):e67904. doi: 10.1371/journal.pone.0067904. Print 2013. PLoS One. 2013. PMID: 23840786 Free PMC article.

7

Development of an MHC class I L(d)-restricted PSA peptide-loaded tetramer for detection of PSA-specific CD8+ T cells in the mouse.

Lemke CD, Graham JB, Lubaroff DM, Salem AK. Lemke CD, et al. Prostate Cancer Prostatic Dis. 2011 Jun;14(2):118-21. doi: 10.1038/pcan.2010.57. Epub 2011 Jan 25. Prostate Cancer Prostatic Dis. 2011. PMID: 21263453 Free PMC article.

8

Chitosan is a surprising negative modulator of cytotoxic CD8+ T cell responses elicited by adenovirus cancer vaccines.

Lemke CD, Graham JB, Geary SM, Zamba G, Lubaroff DM, Salem AK. Lemke CD, et al. Mol Pharm. 2011 Oct 3;8(5):1652-61. doi: 10.1021/mp100464y. Epub 2011 Aug 9. Mol Pharm. 2011. PMID: 21780831 Free PMC article.

9

Proposed mechanisms of action for prostate cancer vaccines.

Geary SM, Lemke CD, Lubaroff DM, Salem AK. Geary SM, et al. Among authors: lemke cd. Nat Rev Urol. 2013 Mar;10(3):149-60. doi: 10.1038/nrurol.2013.8. Epub 2013 Feb 12. Nat Rev Urol. 2013. PMID: 23399727 Free PMC article. Review.

10

Lymphoid hyperplasia resulting in immune dysregulation is caused by porcine reproductive and respiratory syndrome virus infection in neonatal pigs.

Lemke CD, Haynes JS, Spaete R, Adolphson D, Vorwald A, Lager K, Butler JE. Lemke CD, et al. J Immunol. 2004 Feb 1;172(3):1916-25. doi: 10.4049/jimmunol.172.3.1916. J Immunol. 2004. PMID: 14734777

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page